Rhododendron Biotech Pvt. Ltd has been established in 2010 under Company Act as a pharmaceutical company in Nepal to manufacture Hemodialysis Fluid, mainly used for the dialysis patients in Nepal. Our business model is based on the production of Hemodialysis Fluid, Rectified Spirit (B.P Standard) and other pharmaceuticals products in Nepal. Based on the decision of the company to diversify our products; we have now planned to produce other new products like Distilled Water, Chlorhexidine Antiseptic Solution, Povidone Iodine Solution, Calamine Lotion etc.

Partnership With Dolma Impact Fund

In October 2016, Dolma Impact Fund invested in a pharmaceutical company- Rhododendron Biotech Pvt. Ltd (RBPL) and acquired a 49% stake. RBPL’s key products are Haemodialysis Fluid, Rectified Spirit and Distil Water. They plan to expand their product line by manufacturing Tablets, Capsules and other External Liquid Preparations. RBPL is the first company to manufacture Hemodialysis Fluid in Nepal. This investment will provide not only employment opportunities to a skilled and semi-skilled workforce, but also will contribute towards import substitution of the country by expanding their production facilities. Since DIF’s investment, the company has created jobs for 70 people.